[CUSIP No. 16938C106 Page 2 of 5 1 NAMES OF REPORTING PERSONS Chi Sing Ho 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada]
[CUSIP No. 16938C106 Page 2 of 5 1 NAMES OF REPORTING PERSONS Chi Sing Ho 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada]
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Director THIS AGREEMENT (The BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties] [INDEMNIFICATION AGREEMENT Company Indemnitee This Indemnification Agreement, dated as of March 19, 2012, is made by and between China Biologic Products, Inc., a Delaware corporation (the RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Companys officers and directors with adequate and reliable advance knowledge or guidance] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 23, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China (+86) 10-6598-3111 (Former name or former]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer ID No.) 18th Floor, Jialong International Building, (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 5.02. DEPARTURE OF]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer ID No.) 18th Floor, Jialong International Building, (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 5.02. DEPARTURE OF]
[REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin Ling Li lll@ctbb.com.cn DATED: MARCH 15, 2012 To : including all pages If you agree with the proposed action by written consent set forth herein, please sign the accompanying written consent which we will notify the Company in accordance with the Delaware General Corporation Law (the DGCL). Please return the signed written] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 4)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) No. 14 East Hushan Road Tai'an City, Shandong 271000 People's Republic of China (86) 538-620-2306 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 14, 2012]
[REQUEST FOR STOCKHOLDER CONSENT TO ACTION Ms. Lin Ling Li lll@ctbb.com.cn DATED: MARCH 15, 2012 To : including all pages If you agree with the proposed action by written consent set forth herein, please sign the accompanying written consent which we will notify the Company in accordance with the Delaware General Corporation Law (the DGCL). Please return the signed written] [SCHEDULE 13D [Rule 13d-101] (Amendment No. 4)* CHINA BIOLOGIC PRODUCTS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 16938C106 (CUSIP Number) No. 14 East Hushan Road Tai'an City, Shandong 271000 People's Republic of China (86) 538-620-2306 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 14, 2012]
[Company Contact China Biologic Products Reports Results for the Year 2011 Beijing, China, March 12, 2012 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today reported its financial results for the year ended December 31, 2011. Financial highlights for the year 2011] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 12, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
